Innovations

US biopharma firm Amgen to acquire Horizon Therapeutics for nearly $28 bn

0
smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.

The US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.

New biomaterial capable of regenerating bones and preventing infections

Previous article

Tweaked proteins in nasal spray could one day treat COVID-19

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations